Enjoy complimentary customisation on priority with our Enterprise License!
The vitamin D testing market size is estimated to increase by USD 182.6 million and grow at a CAGR of 4.96% between 2023 and 2028. The market is witnessing growth due to factors such as increasing awareness about the importance of vitamin D, facilitated by government and non-government organizations' educational campaigns. These initiatives highlight the benefits and sources of vitamin D, as well as the consequences of its deficiency. The rise in internet penetration among end users has also significantly contributed to the spread of awareness.
For More Highlights About this Report, Download Free Sample in a Minute
The market plays a crucial role in assessing VDD (Vitamin D deficiency), a condition prevalent among individuals with sedentary lifestyles and limited sunlight exposure. With the rise in awareness campaigns and the incidence of serious and chronic diseases like Inflammatory Bowel Disease (IBD), demand for accurate vitamin D assessments is increasing. Diagnostic methods such as radioimmunoassay and HPLC aid in measuring calcium, magnesium, and phosphate levels, essential for maintaining strong bones and preventing bone disorders. Efficient testing is crucial to identify and address abnormal levels, reducing the risk of organ damage and associated medical conditions. There are multiple factors influencing market growth.
The growing prevalence of vitamin D deficiency-related disorders is the key factor driving the growth of the market. Vitamin D deficiency is associated with serious health disorders such as rickets. Rickets is a disease in which bone tissue fails to mineralize properly, causing weak bones and skeletal deformities, especially in children. In addition, a growing number of research studies on vitamin D deficiency have been shown to be associated with several health problems. Low vitamin D levels in the blood are thought to increase the risk of cardiovascular disease, cognitive impairment in the elderly, severe asthma in children, and cancer.
Furthermore, healthcare professionals also routinely test people for vitamin D deficiency because of musculoskeletal symptoms, such as bone pain, muscle aches, and general weakness. Additionally, vitamin D deficiency is associated with an increased risk of diabetes, immune system disorders, and neuropsychiatric disorders. Thus, the association of vitamin D deficiency with several health-related disorders is expected to boost the market during the forecast period.
A growing number of strategic developments by companies is the primary trend in the market. Market players are looking to expand their diagnostic and testing product portfolios through various inorganic growth strategies. M&A helps market players to focus on product innovation, grow profit margins through collaboration, and support technology sharing among players. Through the M&A, both companies will realize economies of scale through large-scale production and distribution, lowering unit prices for such products. As a result, companies like Abbott and bioMerieux are focused on growing product sales through mergers and acquisitions.
Moreover, remarkable M&A activity have been observed in the market. These activities will help the market players to grow and expand their global footprint and leverage existing distribution channels and customer relationships to better serve the needs of patients and caregivers. Thus, the growing number of M and A activities by major players will strengthen the diagnostic capabilities of the company, which will boost the growth of the market during the forecast period.
Product recalls pose challenges to manufacturers that affect the growth of the market. Product recalls impacting on both consumer confidence and a company's brand image, thus impacting both a company's revenue and long-term prospects. This, in turn, affects product sales. Such product recalls hinder the product innovation process of manufacturers and allow competitors to accelerate their innovation efforts to exploit these weaknesses. Timely innovation gives companies a significant advantage in the competitive market.
Moreover, the US FDA recalls products that pose potential health risks to users due to manufacturing defects. wrong reported vitamin D levels can lead to inaccurate vitamin supplement dosages and can lead to serious health problems. Additionally, recall occurrences can become pitfalls and lead to a significant loss for vendors, which will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Beckman Coulter Inc.: The company offers vitamin D testing solution namely Access 25(OH) Vitamin D Total Assay
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the 25-hydroxyvitamin D segment will be significant during the forecast period. One of the nutrients needed for human health is vitamin D, which helps to facilitate functions such as cell growth modulation, neuromuscular and immune function, or reduction in inflammation. Several genes encoding proteins that regulate cell differentiation, proliferation, and apoptosis are modulated in part by vitamin D.
Get a glance at the market contribution of various segments. Download PDF Sample
The 25-hydroxyvitamin D segment was valued at USD 419.6 million in 2018. Two bioequivalent forms of vitamin D, namely vitamin D2, known as ergocalciferol, are obtained from plant-based food sources and oral supplements. Vitamin D3, known as cholecalciferol, is released primarily through skin exposure to ultraviolet B (UVB) radiation found in sunlight and through the consumption of vitamin-rich foods such as fatty fish, fortified foods, and oral supplements. Various market players are offering innovative products to meet the end-users expectations. The increasing prevalence of osteomalacia and rickets among children will drive the growth of the 25-hydroxyvitamin D testing segment of the market during the forecast period.
Diagnostic laboratories include independent testing laboratories and play an important role in the market by offering efficient services such as quantitative chemiluminescent immunoassay. These laboratories require robust and efficient testing instruments such as analyzers, spectroscopes, centrifuges, and auitomated liquid handling systems to obtain precise results as per the standards. Furthermore, vitamin D tests performed in diagnostic laboratories may use radioactive isotopes such as I-125 as tracers and require highly skilled laboratory professionals for effective laboratory management. A shortage of trained professionals poses a significant challenge and could negatively impact increased sales of laboratory-dedicated products. However, training of testing professionals mandated by agencies such as the Centers for Disease Control and Prevention (CDC) could overcome such problems and facilitate the rapid growth in the diagnostic testing sector during the forecast period.
The rising hospitals and physician clinics rate, due to prevalence of chronic conditions such as diabetes, rickets, and osteoporosis, has resulted in a rising number of procedures in hospitals and physician clinics, as vitamin D levels are closely related to such conditions. Moreover, rising access to acute care facilities owing to their growing number further aided in promoting in hospitals. Furthermore, the benefits of integrated care and personal consultations have increased the demand for vitamin D testing in clinics and are expected to boost the adoption of vitamin D testing in hospitals and physician clinics segment during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The North American market has been led by the US due to the presence of numerous vendors such as Abbott, Danaher, and Quest Diagnostics Inc., which offer a wide range of vitamin D testing products in the region. According to the CDC, 25% of the US population is at risk of insufficient vitamin D, and 8% are at risk of deficiency, as defined by the Dietary Reference Intake (DRI) set by the Institute of Medicine. Similarly, the US Department of Agriculture (USDAs) National Nutrient Database highlights the nutrient content of a range of foods and provides an all-inclusive list of foods containing vitamin D arranged by the name of the food and its nutrient content.
Moreover, several studies have shown that vitamin D deficiency is a contributing factor to the development of type 1 and type 2 diabetes, with high rates of diabetes associated with low vitamin D levels in patients in this region. Furthermore, due to the increasing awareness about vitamin D testing, the e US is followed by Canada in terms of revenue contribution. For instance, the Vitamin D Society, a non-profit organization in Canada, works to grow awareness about many health conditions, which are linked to vitamin D deficiency, and encourage all the people in Canada to be proactive and get their vitamin D blood levels tested annually. All these factors are expected to drive the growth of the market in North America.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is experiencing a surge in demand, driven by factors such as the rising prevalence of chronic kidney disease (CKD) and the growing awareness of the importance of 25 hydroxy vitamin D levels. With hospitals, clinics, and standalone clinical laboratories offering testing services, the market caters to various healthcare settings. Deficiencies in vitamin D can lead to various health issues, including fatigue, muscle twitching, and bone changes, making early diagnosis crucial for effective treatment and thereby driving the demand for vitamin ingredients. Technological advancements have led to the development of plasma serum tests with improved accuracy, supported by private agencies and health organizations promoting preventive healthcare. The market's global presence is expanding, driven by new market initiatives and product launches aimed at addressing application dominance and increasing production capacities.
Further, the market is witnessing a surge in demand for 25 hydroxy vitamin D testing, especially in hospitals and clinics, driven by growing awareness of its crucial role in immune system regulation. As a fat-soluble steroid prohormone, vitamin D is essential for calcium, magnesium, and phosphate absorption, impacting overall health. Deficiency can lead to various issues like depression, irritability, and fractures, particularly affecting infants and pregnant women. Diagnostic tests play a vital role in identifying deficiencies, prompting health organizations and healthcare authorities to organize awareness events. With a half-life and technological advancements, the market anticipates new product launches to address growing health concerns related to vitamin D deficiency.
Market Scope |
|
Report Coverage |
Details |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.96% |
Market growth 2024-2028 |
USD 182.6 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.63 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 35% |
Key countries |
US, Germany, China, UK, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Beckman Coulter Inc., Biohit Oyj, bioMerieux SA, BioVendor Laboratorni medicina AS, Boditech Med Inc., DiaSorin SpA, DiaSys Diagnostic Systems GmbH, Everly Health Inc., F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Qualigen Therapeutics Inc., Quest Diagnostics Inc., Quidelortho Corp., Randox Laboratories Ltd., Recipe Chemicals and Instruments GmbH, Revvity Inc., Siemens AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Tosoh Corp. |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market worth and condition analysis for market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.